[Comparative study between prazosin and methyldopa in essential arterial hypertension: results of a parallel, randomized double-blind trial].
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D011224:Prazosin / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D011897:Random Allocation; D012083:Renin / Q000097:blood
D011799:Quinazolines; D006852:Hydrochlorothiazide; D008750:Methyldopa; D012083:Renin; D011224:Prazosin
Estudio comparativo entre prazosin y metildopa en hipertensión arterial esencial: resultados de un ensayo terapeutico paralelo, randomizado y doble ciego.